Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
9.006
Zitationen
8
Autoren
1999
Jahr
Abstract
Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.
Ähnliche Arbeiten
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
1987 · 10.724 Zit.
The Steroid and Thyroid Hormone Receptor Superfamily
1988 · 7.557 Zit.
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 · 6.533 Zit.
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 · 5.954 Zit.
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 · 5.769 Zit.